AriBio and Arcera Sign Exclusive Licensing and Supply Agreements for Investigational Drug for Alzheimer’s Disease
Seongnam-si, South Korea and Abu Dhabi, UAE – June 10, 2025 – AriBio Co., Ltd. (“AriBio”), a South Korean biopharmaceutical company...
News
Acino achieves Level 1 B-BBEE status in South Africa for the sixth year in a row
For the sixth consecutive year, Acino has achieved Level 1 Broad-Based Black Economic Empowerment (B-BBEE) contributor status in South Africa.
29.04.2025Acino Recognized Among Ukraine’s Top 50 Best Employers — Again!
Forbes Ukraine, in collaboration with robota.ua, has once again included Acino in its list of Ukraine's Top 50 Best Employers.
Top Employer 2025: Acino South Africa achieves certification for the fourth consecutive year
We are delighted to announce that Acino South Africa has been recognised as a Top Employer for 2025, marking the...
Thriving Through Change: the Thrilling Story of Maryna Larionova
Maryna Larionova joined Acino Ukraine as an Accountant in August 2017, during a transformative period in her life. Her journey...
Leadership Announcements and New Arcera Structure
Arcera aims to become a global life sciences company, with the purpose of enabling longer and healthier lives while driving...
From Office Assistant to Senior Supply & Demand Officer: Mohammed’s 20-Year Career Journey of Growth and Success at Acino
Mohammed Iqbal stands as a pillar of dedication at Acino. His long-standing tenure is a testament to the inspiring work...
Quality, Efficiency, Safety: Pharma Start Production Site in Ukraine Confirms EU GMP Certification
The Acino production site, Pharma Start, in Ukraine has successfully completed an EU GMP audit.
Acino Publishes Second Annual Sustainability Report
Report underscores Acino’s continued commitment to Environmental, Social, and Governance goals, including a firm commitment to reaching full carbon neutrality...